{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:32:15Z","timestamp":1787841135518,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is becoming one of the most common liver diseases among the Indian population. The predisposing factors for NAFLD are diet, lifestyle modifications, and lack of exercise. There is a paucity of research on NAFLD in the South Indian population. Hence, the present study aimed to assess the prevalence of NAFLD among the urban adult population in Chennai.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>This analytical cross-sectional study was conducted in General Medicine outpatient departments at a tertiary care center in Chennai. The study included 510 non-alcoholic adults (both male and female) aged between 21 and 40 years. Ultrasonography was performed to rule out fatty liver in all participants. All the results obtained were statistically analyzed using SPSS software version 22.0. The frequency was given in percentage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The proportion of participants who screened positive for NAFLD was 61.5%. The participants with higher body mass index (BMI) were found to be significantly 23.09 times higher risk of developing NAFLD. An increase in age was also found to be a predictor of NAFLD. This study also supports that males are more prone to develop NAFLD and are at a 1.59% higher risk of developing the disease than females.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Fatty liver has become one of the common non-communicable diseases in India, the high prevalence of NAFLD in the present study supports it. Therefore, people should have regular screening and diagnosis to rule out fatty liver disease. Proper diet patterns and exercise must be followed to prevent fatty liver.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijcm.ijcm_437_22","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T08:08:00Z","timestamp":1689235680000},"page":"601-604","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of Non-Alcoholic Fatty Liver Disease in Urban Adult Population in a Tertiary Care Center, Chennai"],"prefix":"10.4103","volume":"48","author":[{"given":"Mary Chandrika","family":"Anton","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Bhaarath Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Shanthi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaganti","family":"Sridevi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Prathima Relief Institute of Medical Sciences, Warangal, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"R1-20260330","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"R2-20260330","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease. 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"R3-20260330","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"key":"R4-20260330","year":"2021"},{"key":"R5-20260330","first-page":"41","article-title":"The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease","volume":"6","author":"Iqbal","year":"2019","journal-title":"Medicines (Basel)"},{"key":"R6-20260330","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"R7-20260330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body mass index","volume":"50","author":"Nuttall","year":"2015","journal-title":"Nutr Today"},{"key":"R8-20260330","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: New insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"key":"R9-20260330","first-page":"7449","article-title":"A randomized controlled trial comparing the effects of Vitamin E, ursodeoxycholic acid and pentoxifylline on Egyptian non-alcoholic steatohepatitis patients","volume":"25","author":"Fouda","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R10-20260330","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.3390\/ijerph16203987","article-title":"The prevalence of overweight, obesity, hypertension, and diabetes in India: Analysis of the 2015\u20132016 National Family Health Survey","volume":"16","author":"Vennu","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"R11-20260330","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.3748\/wjg.v20.i42.15532","article-title":"Liver transplantation and non-alcoholic fatty liver disease","volume":"20","author":"Zezos","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R12-20260330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R13-20260330","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"R14-20260330","first-page":"158","article-title":"Nonalcoholic fatty liver disease: Indian perspective","volume":"18","author":"De","year":"2021","journal-title":"CLD Rev J"},{"key":"R15-20260330","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: Population-based study","volume":"6","author":"Amarapurkar","year":"2007","journal-title":"Ann Hepatol"},{"key":"R16-20260330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0019-557X.177295","article-title":"Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India","volume":"60","author":"Majumdar","year":"2016","journal-title":"Indian J Public Health"},{"key":"R17-20260330","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13244-014-0336-2","article-title":"Ultrasound in chronic liver disease","volume":"5","author":"Gerstenmaier","year":"2014","journal-title":"Insights Imaging"},{"key":"R18-20260330","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12876-019-0972-6","article-title":"Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States","volume":"19","author":"Golabi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R19-20260330","doi-asserted-by":"crossref","first-page":"e0263768","DOI":"10.1371\/journal.pone.0263768","article-title":"Rural-Urban differentials in prevalence, spectrum, and determinants of non-alcoholic fatty liver disease in North Indian population","volume":"17","author":"Asadullah","year":"2022","journal-title":"PLoS One"}],"container-title":["Indian Journal of Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_437_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:43:09Z","timestamp":1787838189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_437_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijcm.ijcm_437_22","relation":{},"ISSN":["0970-0218","1998-3581"],"issn-type":[{"value":"0970-0218","type":"print"},{"value":"1998-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-05-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}